Theratechnologies  logo

Theratechnologies THTX

report update icon

Annual report 2024
added 04-25-2026

Country

canadaCanada

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

Shares

-

Market Cap[1]

$ 83.9 M

EBITDA (LTM)

-

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
$ 9.52 5.01 % $ 752 M Nasdaq Global Market usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
- -8.77 % $ 12.4 M Nasdaq Global Select Market israelIsrael
Berkeley Lights Berkeley Lights
BLI
- -7.31 % $ 87 M Nasdaq Global Select Market usaUSA
Histogen Histogen
HSTO
- 31.6 % $ 2.12 M Nasdaq Global Select Market usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
$ 24.02 0.39 % $ 3.64 B Nasdaq Global Select Market,SPB usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
$ 17.61 2.63 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Achieve Life Sciences Achieve Life Sciences
ACHV
$ 6.38 0.79 % $ 278 M Nasdaq Capital Market usaUSA
ImmunoGen ImmunoGen
IMGN
- - $ 7.92 B Nasdaq Global Select Market usaUSA
Precision BioSciences Precision BioSciences
DTIL
$ 5.77 2.32 % $ 74 M Nasdaq Global Select Market usaUSA
Editas Medicine Editas Medicine
EDIT
$ 2.35 7.49 % $ 209 M Nasdaq Global Select Market,SPB usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
$ 84.95 0.13 % $ 7.99 B Nasdaq Global Select Market usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
$ 31.32 4.36 % $ 1.82 B Nasdaq Global Select Market,SPB usaUSA
Enanta Pharmaceuticals Enanta Pharmaceuticals
ENTA
$ 11.1 2.59 % $ 237 K Nasdaq Global Select Market,SPB usaUSA
Exelixis Exelixis
EXEL
$ 62.23 0.06 % $ 16.9 B Nasdaq Global Select Market,SPB usaUSA
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
$ 2.99 4.32 % $ 219 K Nasdaq Global Market usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
$ 0.17 1.53 % $ 275 K NYSE American usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
- - $ 1.41 B Nasdaq Global Market usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
- - $ 591 K Nasdaq Global Select Market irlandaIrlanda
Akebia Therapeutics Akebia Therapeutics
AKBA
$ 0.67 0.14 % $ 172 M Nasdaq Global Market usaUSA
GlaxoSmithKline plc GlaxoSmithKline plc
GSK
$ 49.51 1.0 % $ 201 B NYSE britainBritain
GT Biopharma GT Biopharma
GTBP
$ 7.03 18.52 % $ 38.8 M Nasdaq Capital Market usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
$ 0.36 4.01 % $ 60 M Nasdaq Global Select Market,SPB usaUSA
Johnson & Johnson Johnson & Johnson
JNJ
$ 255.56 0.86 % $ 615 B NYSE,SPB usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
$ 8.18 19.02 % $ 551 B Nasdaq Capital Market britainBritain
Clovis Oncology Clovis Oncology
CLVS
- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
$ 28.82 10.19 % $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Aldeyra Therapeutics Aldeyra Therapeutics
ALDX
$ 0.7 0.62 % $ 42 M Nasdaq Global Select Market usaUSA
Kura Oncology Kura Oncology
KURA
$ 9.08 0.94 % $ 796 M Nasdaq Global Select Market usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
- - $ 401 M Nasdaq Global Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
- - $ 231 M Nasdaq Global Market usaUSA
Kaleido Biosciences Kaleido Biosciences
KLDO
- -3.69 % $ 12.4 M Nasdaq Global Select Market usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
$ 34.99 3.77 % $ 147 M Nasdaq Global Select Market usaUSA
Alector Alector
ALEC
$ 1.84 6.02 % $ 190 M Nasdaq Global Select Market,SPB usaUSA
ObsEva SA ObsEva SA
OBSV
- -15.52 % $ 10.5 M Nasdaq Global Select Market schweizSchweiz
Kronos Bio Kronos Bio
KRON
- 1.49 % $ 50.8 M Nasdaq Global Select Market usaUSA
Landos Biopharma Landos Biopharma
LABP
- 0.58 % $ 144 M Nasdaq Global Market usaUSA
PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals
PHAS
- 7.4 % $ 6.29 M Nasdaq Global Market usaUSA
Provention Bio Provention Bio
PRVB
- - $ 2.37 B Nasdaq Global Select Market usaUSA
Poseida Therapeutics Poseida Therapeutics
PSTX
- - $ 857 M Nasdaq Global Select Market usaUSA
PolarityTE PolarityTE
PTE
- -0.82 % $ 1.78 M Nasdaq Capital Market usaUSA
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
- - $ 6.29 B Nasdaq Global Market,SPB usaUSA
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
- -45.12 % $ 2.85 M Nasdaq Global Select Market usaUSA
ALX Oncology Holdings ALX Oncology Holdings
ALXO
$ 1.06 6.0 % $ 56.9 M Nasdaq Global Select Market,SPB usaUSA
Lineage Cell Therapeutics Lineage Cell Therapeutics
LCTX
$ 0.98 0.09 % $ 226 M NYSE American usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
- - $ 23.9 M Nasdaq Global Select Market usaUSA
Satsuma Pharmaceuticals Satsuma Pharmaceuticals
STSA
- -0.9 % $ 36.5 M Nasdaq Global Market usaUSA
SpringWorks Therapeutics SpringWorks Therapeutics
SWTX
- - $ 3.48 B Nasdaq Global Select Market,SPB usaUSA
Trevena Trevena
TRVN
- -46.58 % $ 31.8 M Nasdaq Capital Market usaUSA
Oncorus Oncorus
ONCR
- -8.54 % $ 3.19 M Nasdaq Global Market usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
- 31.87 % $ 1.61 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.